This guidance explains upcoming packaging changes for UK-licensed medicines, effective 1 January 2025, and confirms that these medicines can still be exported globally.

Key Points:

• The Windsor Framework, agreed in February 2023, transfers medicines authorized under EU regulations to UK law, removing the Falsified Medicines Directive safety features.
• From 1 January 2025, all UK medicines must be labelled ‘UK Only’ to prevent movement into the EU, while maintaining consistent UK packaging.
• MHRA assures that 'UK Only' labelling does not restrict exports to non-EU countries, provided local import laws are met.
• Marketing authorisation holders can export without restrictions, though export by other companies is limited during UK shortages, with a regularly updated banned export list from the Department of Health and Social Care.
• Exporting companies must comply with both UK and destination country laws.

Source:

MHRA: UK medicines export and Windsor Framework labelling requirements